As of 2024-12-14, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -3.53. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 74.07 mil USD. Apyx's TTM EBITDA according to its financial statements is -20.96 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 22.0x | 21.7x |
| Forward P/E multiples | 21.2x - 22.6x | 21.8x |
| Fair Price | (11.10) - (11.53) | (11.37) |
| Upside | -760.5% - -786.3% | -776.6% |
| Date | EV/EBITDA |
| 2024-12-05 | -3.24 |
| 2024-12-04 | -3.28 |
| 2024-12-03 | -3.48 |
| 2024-12-02 | -3.96 |
| 2024-11-29 | -3.40 |
| 2024-11-27 | -3.55 |
| 2024-11-26 | -3.09 |
| 2024-11-25 | -3.07 |
| 2024-11-22 | -3.08 |
| 2024-11-21 | -3.03 |
| 2024-11-20 | -2.99 |
| 2024-11-19 | -2.76 |
| 2024-11-18 | -2.66 |
| 2024-11-15 | -2.72 |
| 2024-11-14 | -2.78 |
| 2024-11-13 | -2.88 |
| 2024-11-12 | -2.93 |
| 2024-11-11 | -3.15 |
| 2024-11-08 | -3.22 |
| 2024-11-07 | -2.64 |
| 2024-11-06 | -2.62 |
| 2024-11-05 | -2.55 |
| 2024-11-04 | -2.53 |
| 2024-11-01 | -2.59 |
| 2024-10-31 | -2.55 |
| 2024-10-30 | -2.66 |
| 2024-10-29 | -2.70 |
| 2024-10-28 | -2.74 |
| 2024-10-25 | -2.62 |
| 2024-10-24 | -2.41 |
| 2024-10-23 | -2.43 |
| 2024-10-22 | -2.49 |
| 2024-10-21 | -2.55 |
| 2024-10-18 | -2.57 |
| 2024-10-17 | -2.59 |
| 2024-10-16 | -2.66 |
| 2024-10-15 | -2.57 |
| 2024-10-14 | -2.53 |
| 2024-10-11 | -2.57 |
| 2024-10-10 | -2.60 |
| 2024-10-09 | -2.59 |
| 2024-10-08 | -2.64 |
| 2024-10-07 | -2.74 |
| 2024-10-04 | -2.75 |
| 2024-10-03 | -2.64 |
| 2024-10-02 | -2.59 |
| 2024-10-01 | -2.64 |
| 2024-09-30 | -2.68 |
| 2024-09-27 | -2.60 |
| 2024-09-26 | -2.56 |